We would like to thank our exhibitors and sponsors for sponsoring this meeting. This includes pharmaceutical companies including AstraZeneca UK. They have had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations.

Agenda

Thursday, October 1, 2026
9:20 AM - 10:15 AM
Chair’s opening remarks followed by: Interstitial lung disease: recognising the signs early
  • Overview of ILD subtypes and why early identification matters 
  • Key symptoms, examination findings and clinical features that warrant urgent referral
  • Interpreting initial investigations: spirometry, imaging and blood tests 
  • The role of MDTs and specialist centres in improving outcomes 
Helena Beer, Editor, Hospital Healthcare Europe, Hospital Pharmacy Europe
Richard Hewitt, Consultant Respiratory Physician, Royal Brompton Hospital
10:30 AM - 11:15 AM
Optimizing COPD triple therapy at ED discharge: a quality improvement initiative to reduce exacerbations and improve outcomes
  • An ED discharge optimization gap for COPD patients means many are not on optimal therapy, leading to frequent early reattendance
  • The initiative promotes proactive, guideline-directed triple therapy optimization to reduce exacerbations and improve lung function
Dr Dan Neville, Consultant Respiratory Physician, Portsmouth Hospitals University NHS Trust
Paula Browne, Senior Respiratory Nurse Specialist, Norfolk & Norwich University Hospital Trust

This is a promotional symposium sponsored and organised by AstraZeneca and is intended for UK HCPs only.

11:30 AM - 12:15 PM
Delivering airways clearance (OPEP focus)
  • Understanding the role of Oscillating Positive Expiratory Pressure (OPEP therapy)
  • Explore practical techniques and best practice approaches for delivering effective airway clearance using OPEP devices
  • Review real-world clinical considerations and common challenges
David Barber, Advanced Practitioner, Specialist Respiratory Physiotherapist, Liverpool Heart and Chest Hospital NHS Foundation Trust

Sponsored by: 

12:30 PM - 1:15 PM
Pulmonary embolism beyond the acute event: long-term consequences and follow-up
  • Changing epidemiology and risk factors, including cancer and chronic disease 
  • Optimising anticoagulation: duration, choice of agent, and patient safety 
  • Recognising post-PE syndrome and chronic thromboembolic disease 
  • Follow-up strategies in primary care and when to re-refer 
David Kiely, Consultant Respiratory Physician, Professor of Pulmonary Vascular Medicine, Sheffield Teaching Hospitals NHS Foundation Trust
1:30 PM - 2:15 PM
Respiratory health inequalities: reaching underserved populations
  • Understanding disparities in diagnosis, access, and outcomes 
  • The impact of socioeconomic factors, housing, and occupational exposure 
  • Practical interventions in primary care to reduce inequality 
  • Using data and MDT working to target high-risk groups 
Ian Sinha, Consultant Respiratory Paediatrician, Alder Hey Children’s Hospital Liverpool; Honorary Professor of Child Health, University of Liverpool; Honorary Professor of Global Child Health, Liverpool School of Tropical Medicine

If you are interested in sponsoring a session on the Agenda, or sponsoring the event please contact Ed Burkle, Event Sales Director.

REGISTER FOR FREE

Speakers